Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Series D
Preferred Stock
Series E
Preferred Stock
Series F
Preferred Stock
Series F-1
Preferred Stock
Series F-2
Preferred Stock
Common Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021         $ 1 $ 82,677 $ (73,690) $ 8,988
Balance (in Shares) at Dec. 31, 2021 251 1,443 500,756           242,808      
Delivery of restricted common stock         $ 1 1
Delivery of restricted common stock (in Shares)                 18,255      
Issuance of common stock and warrants, net of fees         855 855
Issuance of common stock and warrants, net of fees (in Shares)                 20,834      
Issuance of common stock warrants in connection with SLOC         223 223
Issuance of Series D preferred stock and warrants, net of fees         1,039 1,039
Issuance of Series D preferred stock and warrants, net of fees (in Shares)       1,058                
Issuance of common stock/at-the-market offering, net of offering costs         706 706
Issuance of common stock/at-the-market offering, net of offering costs (in Shares)                 27,462      
Issuance of common stock warrants in connection with consideration payable         86 86
Stock-based compensation         3,011 3,011
Net loss                     (12,163) (12,163)
Balance at Sep. 30, 2022         $ 2 88,597 (85,853) 2,746
Balance (in Shares) at Sep. 30, 2022 251 1,443 500,756 1,058         309,359      
Balance at Jun. 30, 2022             85,489 (82,737) 2,753
Balance (in Shares) at Jun. 30, 2022 251 1,443 500,756                  
Delivery of restricted common stock             1
Issuance of common stock and warrants, net of fees             855   855
Issuance of Series D preferred stock and warrants, net of fees             1,039   1,039
Issuance of common stock/at-the-market offering, net of offering costs             648   648
Issuance of common stock warrants in connection with consideration payable             86   86
Stock-based compensation             480   480
Net loss                     (3,116) (3,116)
Balance at Sep. 30, 2022         $ 2 88,597 (85,853) 2,746
Balance (in Shares) at Sep. 30, 2022 251 1,443 500,756 1,058         309,359      
Balance at Dec. 31, 2022 $ 2 88,533 (88,005) 530
Balance (in Shares) at Dec. 31, 2022 251 1,443 500,756 1,058         338,033      
Exercise of common stock warrants $ 1 2,061 2,062
Exercise of common stock warrants (in Shares)                 109,257      
Issuance of common stock in connection with conversion of notes 516 516
Issuance of common stock in connection with conversion of notes (in Shares)                 31,466      
Issuance of common stock in connection with equity line of credit 4,489 4,489
Issuance of common stock in connection with equity line of credit (in Shares)                 3,986,991      
Issuance of common stock/at-the-market offering, net of offering costs $ 1 3,786 3,787
Issuance of common stock/at-the-market offering, net of offering costs (in Shares)                 794,689      
Issuance of Series E preferred stock in connection with LOC 4,350 4,350
Issuance of Series E preferred stock in connection with LOC (in Shares)         5,000              
Deemed dividend for repricing of Series D preferred stock 6 (6)
Commitment to issue shares of common stock in connection with March waiver agreement 298 298
Issuance of common stock in connection with Series A and Series B Dividends
Issuance of common stock in connection with Series A and Series B Dividends (in Shares)                 6,921      
Issuance of common stock upon the conversion of Series E preferred stock $ 1 1
Issuance of common stock upon the conversion of Series E preferred stock (in Shares)         (5,000)       83,334      
Issuance of common stock in connection with conversion of October Notes $ 1 2,165 2,166
Issuance of common stock in connection with conversion of October Notes (in Shares)                 248,984      
Dividends paid in shares of Series D preferred stock
Dividends paid in shares of Series D preferred stock (in Shares)       139                
Series D preferred stock exchanged for Series F preferred stock in connection with Exchange Agreements (450) (450)
Series D preferred stock exchanged for Series F preferred stock in connection with Exchange Agreements (in Shares)       (1,197)   1,847            
Conversion of Demand Notes and October Notes into Series F preferred stock in connection with Exchange Agreements 1,276 1,276
Conversion of Demand Notes and October Notes into Series F preferred stock in connection with Exchange Agreements (in Shares)           3,198            
Conversion of January Notes into Series F preferred stock in connection with Exchange Agreements 82 82
Conversion of January Notes into Series F preferred stock in connection with Exchange Agreements (in Shares)           206            
Issuance of Series F-1 preferred stock 1,372 1,372
Issuance of Series F-1 preferred stock (in Shares)             3,583          
Issuance of Series F-2 preferred stock 464 464
Issuance of Series F-2 preferred stock (in Shares)               1,153        
Conversion of Series F preferred stock into common stock
Conversion of Series F preferred stock into common stock (in Shares)           (803)     103,234      
Conversion of Series F-1 preferred stock into common stock
Conversion of Series F-1 preferred stock into common stock (in Shares)             (2,930)   325,737      
Commitment to issue shares of common stock in connection with January Notes 2,410 2,410
Commitment to issue shares of common stock in connection with LOC Notes 230 230
Commitment to issue shares of Series E preferred stock in connection with LOC Notes 3,363 3,363
Commitment to issue shares of common stock in connection with Demand Notes 286 286
Issuance of common stock to settle commitment shares $ 1 (1)
Issuance of common stock to settle commitment shares (in Shares)                 570,916      
Issuance of common stock in connection with January Notes Settlement 1,160 1,160
Issuance of common stock in connection with January Notes Settlement (in Shares)                 189,602      
Issuance of common stock in connection with equity line of credit 114 114
Issuance of common stock in connection with equity line of credit (in Shares)                 21,841      
Reverse stock split rounding
Reverse stock split rounding (in Shares)                 30,709      
Stock-based compensation 446 446
Stock-based compensation (in Shares)                 38,335      
Net loss                     (19,678) (19,678)
Balance at Sep. 30, 2023 $ 7 116,956 (107,689) 9,274
Balance (in Shares) at Sep. 30, 2023 251 1,443 500,756     4,448 653 1,153 6,880,049      
Balance at Jun. 30, 2023 $ 6 109,381 (104,830) 4,557
Balance (in Shares) at Jun. 30, 2023 251 1,443 500,756     5,251 3,583 1,153 1,067,997      
Issuance of common stock in connection with equity line of credit 114 114
Issuance of common stock in connection with equity line of credit (in Shares)                 21,841      
Issuance of common stock under the equity line of credit, net of issuance costs 4,489 4,489
Issuance of common stock under the equity line of credit, net of issuance costs (in Shares)                 3,986,991      
Issuance of common stock/at-the-market offering, net of offering costs 1,680 1,680
Issuance of common stock/at-the-market offering, net of offering costs (in Shares)                 583,022      
Conversion of Series F preferred stock into common stock
Conversion of Series F preferred stock into common stock (in Shares)           (803)     103,234      
Conversion of Series F-1 preferred stock into common stock (2,930)
Conversion of Series F-1 preferred stock into common stock (in Shares)                 325,737      
Issuance of common stock to settle commitment shares $ 1 (1)
Issuance of common stock to settle commitment shares (in Shares)                 570,916      
Issuance of common stock in connection with January Notes Settlement 1,160 1,160
Issuance of common stock in connection with January Notes Settlement (in Shares)                 189,602      
Reverse stock split rounding
Reverse stock split rounding (in Shares)                 30,709      
Stock-based compensation 133 133
Net loss                     (2,859) (2,859)
Balance at Sep. 30, 2023 $ 7 $ 116,956 $ (107,689) $ 9,274
Balance (in Shares) at Sep. 30, 2023 251 1,443 500,756     4,448 653 1,153 6,880,049